Precisely defined polymers for highly effective and accurate detection, monitoring and treatment of malignant diseases

Project Summary

Preparation of precisely-defined biomaterials is critical for achieving highly effective and accurate detection, monitoring and accurate treatment of diseases. However, the development of highly-effective molecular agents is hindered by current synthetic strategies. Although synthetic macromolecules and polymers are often termed ‘monodisperse’ and widely used as biomaterials for the delivery of drugs and probes, their primary structures are not as perfectly controlled as natural macromolecules, such as proteins and nucleic acid.

With the collaborations between CBNS and University of California, Santa Barbara researchers, we have developed a new synthetic method to prepare a range of truly discrete materials for various biological applications.